12/20/2024
4:32 PM | Kaupinen Wes (Filed by)
PALVELLA THERAPEUTICS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form SCHEDULE 13D | |
12/20/2024
3:56 PM | PALVELLA THERAPEUTICS, INC. (Subject)
Palvella Therapeutics (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SCHEDULE 13G | |
12/20/2024
3:59 PM | PALVELLA THERAPEUTICS, INC. (Subject)
Palvella Therapeutics (Subject)
Samsara BioCapital, L.P. (Filed by)
| Form SCHEDULE 13G | |
12/19/2024
9:23 AM | JENKINS GEORGE M (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
7:45 PM | PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Wessel Tadd S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
7:46 PM | HERON ELAINE J (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
7:40 PM | KIRITSY CHRISTOPHER P (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
12/17/2024
7:41 PM | Kaupinen Wes (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
7:42 PM | JENKINS GEORGE M (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
7:43 PM | Korenberg Matthew E (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
7:43 PM | Goin Kathleen (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
7:44 PM | Martini Jeffrey S (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
7:44 PM | Davis Todd C (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
4:42 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
PALVELLA THERAPEUTICS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form SC 13G/A | |
12/17/2024
4:44 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
3:22 PM | Dellora Investments LP (Filed by)
PALVELLA THERAPEUTICS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
12/16/2024
6:40 PM | HERON ELAINE J (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/16/2024
6:41 PM | Davis Todd C (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/16/2024
6:41 PM | JENKINS GEORGE M (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/16/2024
6:42 PM | Martini Jeffrey S (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/16/2024
6:43 PM | Goin Kathleen (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/16/2024
6:43 PM | Kaupinen Wes (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/16/2024
6:44 PM | PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
Wessel Tadd S. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/16/2024
6:44 PM | Korenberg Matthew E (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/16/2024
3:18 PM | Dellora Investments LP (Reporting)
PALVELLA THERAPEUTICS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
8:53 PM | PALVELLA THERAPEUTICS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2024
3:15 PM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2024
3:15 PM | PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form 425 | |
12/12/2024
3:16 PM | GERAGHTY JAMES A (Reporting)
PIERIS PHARMACEUTICALS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
6:32 AM | KIRITSY CHRISTOPHER P (Reporting)
PIERIS PHARMACEUTICALS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
1:21 PM | Dellora Investments LP (Filed by)
PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
12/03/2024
7:30 AM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/03/2024
7:30 AM | PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form 425 | |
11/18/2024
3:16 PM | Dellora Investments LP (Reporting)
PIERIS PHARMACEUTICALS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/14/2024
8:07 AM | Lynx1 Capital Management LP (Filed by)
PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form SC 13G/A | |
11/13/2024
3:02 PM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
8:01 AM | PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form 425 | |
11/07/2024
7:47 AM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form S-4/A | |
11/06/2024
4:00 PM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form ARS | |
11/06/2024
4:01 PM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form DEF 14A | |
11/05/2024
4:01 PM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form S-4/A | |
Could This Tiny Device Help You Make an Extra $30k a Year? (Ad) I believe it’s going to power Elon Musk’s next AI revolution…
A revolution he believes will be worth more than $9 trillion.
That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED. Click here to see the details because I believe a lot of people will get rich. |
10/29/2024
7:45 AM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form S-4/A | |
10/28/2024
4:18 PM | GERAGHTY JAMES A (Reporting)
PIERIS PHARMACEUTICALS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2024
7:00 AM | PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form 425 | |
10/15/2024
7:30 AM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form S-4/A | |
10/15/2024
7:00 AM | PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form 425 | |
10/03/2024
7:00 AM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
7:00 AM | PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form 425 | |
09/23/2024
5:15 AM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form S-4/A | |
08/12/2024
5:48 PM | ADAR1 Capital Management, LLC (Reporting)
ADAR1 Partners, LP (Reporting)
PIERIS PHARMACEUTICALS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
4:29 PM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
08/07/2024
1:16 PM | Dellora Investments LP (Filed by)
PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form SCHEDULE 13G | |
08/01/2024
7:00 AM | ADAR1 Capital Management, LLC (Filed by)
PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form SC 13G | |
07/31/2024
6:26 PM | ADAR1 Capital Management, LLC (Reporting)
ADAR1 Partners, LP (Reporting)
PIERIS PHARMACEUTICALS, INC. (Issuer)
Palvella Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/24/2024
5:40 AM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2024
5:40 AM | PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form 425 | |
07/03/2024
3:32 PM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
7:00 AM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/18/2024
3:21 PM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
4:31 PM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/27/2024
7:00 AM | PIERIS PHARMACEUTICALS, INC. (Filer)
Palvella Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
12:12 PM | Checkpoint Capital L.P. (Filed by)
PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
8:19 AM | Lynx1 Capital Management LP (Filed by)
PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
| Form SC 13G/A | |
02/02/2024
8:59 AM | PIERIS PHARMACEUTICALS, INC. (Subject)
Palvella Therapeutics (Subject)
Soleus Capital Master Fund, L.P. (Filed by)
| Form SC 13G/A | |
